Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist.
Fabrizi
F
F
Locatelli
F
F
D000998:Antiviral Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D006526:Hepatitis C / Q000150:complications / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000821:virology; D009398:Nephrology / Q000379:methods; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D004338:Drug Combinations; D016898:Interferon-alpha; D012254:Ribavirin